Dr. Martens plc
DOCS.L · LSE
9/30/2025 | 3/31/2025 | 3/30/2025 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | £322 | – | £463 | £325 |
| % Growth | – | – | 42.6% | – |
| Cost of Goods Sold | £146 | – | £159 | £117 |
| Gross Profit | £176 | – | £304 | £208 |
| % Margin | 54.6% | – | 65.7% | 64% |
| R&D Expenses | £0 | – | £0 | £0 |
| G&A Expenses | £0 | – | £0 | £0 |
| SG&A Expenses | £172 | – | £156 | £223 |
| Sales & Mktg Exp. | £0 | – | £0 | £0 |
| Other Operating Expenses | £0 | – | £77 | £0 |
| Operating Expenses | £172 | – | £233 | £223 |
| Operating Income | £3 | – | £71 | -£15 |
| % Margin | 1% | – | 15.4% | -4.7% |
| Other Income/Exp. Net | -£14 | – | -£34 | -£14 |
| Pre-Tax Income | -£11 | – | £38 | -£29 |
| Tax Expense | -£1 | – | £12 | -£8 |
| Net Income | -£10 | – | £25 | -£21 |
| % Margin | -3.1% | – | 5.5% | -6.4% |
| EPS | -0.01 | – | 0.026 | -0.022 |
| % Growth | – | – | 219.5% | – |
| EPS Diluted | -0.01 | – | 0.026 | -0.022 |
| Weighted Avg Shares Out | 966 | – | 962 | 945 |
| Weighted Avg Shares Out Dil | 966 | – | 964 | 945 |
| Supplemental Information | – | – | – | – |
| Interest Income | £2 | – | £2 | £0 |
| Interest Expense | £14 | – | £17 | £14 |
| Depreciation & Amortization | £35 | – | £62 | £11 |
| EBITDA | £38 | – | £115 | -£5 |
| % Margin | 11.7% | – | 24.8% | -1.4% |